After pulling off a surprise third-quarter beat and full-year guidance raise amid shareholder activism earlier this year, Pfizer now expects its 2025 revenues to come in the same range as in 2024.
Pfizer on Tuesday confirmed its projection of achieving $61 billion to $64 billion in 2024 revenue. The company also shared its outlook for 2025, providing a revenue forecast with the exact same range.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,